We assessed whether long-term LRRK2 inhibition by GNE-7915 caused renal effects, including changes in kidney gross morphology, serum creatinine levels, and urinary ACR (a marker of early renal diseases or diabetic nephropathy). Here, LRRK2 is linked to diabetic kidney disease.